Historical salary details - Mr. Jean-Jacques Bienaime, Director, Biomarin Pharmaceutical Inc. - Registered Shares
Mr. Jean-Jacques Bienaime is the Director of Biomarin Pharmaceutical Inc. - Registered Shares. They also hold 2 other positions in Keros Therapeutics Inc and Incyte Corp..
Mr. Jean-Jacques Bienaime
Director
$ 2.5 M
Gross Remuneration
-
Current Company
Biomarin Pharmaceutical Inc. - Registered Shares
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Biomarin Pharmaceutical Inc. - Registered Shares | Director | 1.4 M | - |
| 2024 | Keros Therapeutics Inc | Lead Independent Director | 652.9 K | - |
| 2024 | Incyte Corp. | Independent Director | 518.2 K | 8.2 % |
| 2023 | Incyte Corp. | Independent Director | 478.8 K | -1.2 % |
| 2023 | Biomarin Pharmaceutical Inc. - Registered Shares | Director | - | - |
| 2023 | Biomarin Pharmaceutical Inc. - Registered Shares | Director | - | - |
| 2022 | Incyte Corp. | Independent Director | 484.7 K | 3.2 % |
| 2022 | Biomarin Pharmaceutical Inc. - Registered Shares | Chairman of the Board and Chief Executive Officer | - | - |
| 2021 | Incyte Corp. | Independent Director | 469.5 K | -20.5 % |
| 2021 | Biomarin Pharmaceutical Inc. - Registered Shares | Chairman of the Board and Chief Executive Officer | - | - |
| 2020 | Incyte Corp. | Independent Director | 590.7 K | 13.1 % |
| 2020 | Biomarin Pharmaceutical Inc. - Registered Shares | Chairman of the Board and Chief Executive Officer | - | - |
| 2019 | Incyte Corp. | Independent Director | 522.5 K | 7.6 % |
| 2019 | Biomarin Pharmaceutical Inc. - Registered Shares | Chairman of the Board and Chief Executive Officer | - | - |
| 2018 | Incyte Corp. | Independent Director | 485.4 K | -53.1 % |
| 2018 | Immunic Inc | - | 155.0 K | 4.3 % |
| 2018 | Immunic Inc | Independent Director | - | - |
| 2018 | Biomarin Pharmaceutical Inc. - Registered Shares | Chairman of the Board and Chief Executive Officer | - | - |
| 2017 | Incyte Corp. | Independent Director | 1.0 M | 54.1 % |
| 2017 | Immunic Inc | Independent Director | 148.5 K | -10.6 % |
| 2017 | Biomarin Pharmaceutical Inc. - Registered Shares | Chairman of the Board and Chief Executive Officer | - | - |
| 2016 | Incyte Corp. | Independent Director | 671.1 K | -16.5 % |
| 2016 | Immunic Inc | Independent Director | 166.2 K | 9.7 % |
| 2016 | Biomarin Pharmaceutical Inc. - Registered Shares | Chairman of the Board and Chief Executive Officer | - | - |
| 2015 | Incyte Corp. | Director | 803.3 K | - |
| 2015 | Immunic Inc | Independent Director | 151.5 K | 138.6 % |
| 2015 | Biomarin Pharmaceutical Inc. - Registered Shares | Chairman of the Board and Chief Executive Officer | - | - |
| 2014 | Immunic Inc | Independent Director | 63.5 K | -88.7 % |
| 2014 | Incyte Corp. | Independent Director | - | - |
| 2014 | Biomarin Pharmaceutical Inc. - Registered Shares | Director and Chief Executive Officer | - | - |
| 2013 | Immunic Inc | Independent Director | 560 K | - |
| 2013 | Biomarin Pharmaceutical Inc. - Registered Shares | Director and Chief Executive Officer | - | - |
| 2012 | Immunic Inc | Independent Director | - | - |
| 2012 | Biomarin Pharmaceutical Inc. - Registered Shares | Director and Chief Executive Officer | - | - |
| 2011 | Biomarin Pharmaceutical Inc. - Registered Shares | Director and Chief Executive Officer | - | - |
| 2010 | Biomarin Pharmaceutical Inc. - Registered Shares | Director and Chief Executive Officer | - | - |
| 2009 | Biomarin Pharmaceutical Inc. - Registered Shares | Director and Chief Executive Officer | - | - |
| 2008 | Biomarin Pharmaceutical Inc. - Registered Shares | Director and Chief Executive Officer | - | - |
| 2007 | Biomarin Pharmaceutical Inc. - Registered Shares | Director and Chief Executive Officer | - | - |
| 2006 | Biomarin Pharmaceutical Inc. - Registered Shares | Director and Chief Executive Officer | - | - |
| 2005 | Biomarin Pharmaceutical Inc. - Registered Shares | Chief Executive Officer and Director | - | - |
| 2004 | Biomarin Pharmaceutical Inc. - Registered Shares | Chief Executive Officer and Director | - | - |